• Ownership

Claude Nicaise - Insider Trading & Ownership

Entity
Individual
Location
215 First Street, Suite 415, Cambridge, MA
Summary
The estimated net worth of Claude Nicaise is at least $3.03M dollars as of March 13, 2025. Claude Nicaise is the Director of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $2.77M. Claude Nicaise is the Director of CASSAVA SCIENCES INC and owns shares of CASSAVA SCIENCES INC (SAVA) stock worth about $169K. Claude Nicaise is the Director of Gain Therapeutics, Inc. and owns shares of Gain Therapeutics, Inc. (GANX) stock worth about $87.9K.
All Insider Reports
All Insider Reports

Ownership of Claude Nicaise

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRPT Sarepta Therapeutics, Inc. Director $2.77M -$248K -8.22% Mar 12, 2025
SAVA CASSAVA SCIENCES INC Director $169K May 9, 2024
GANX Gain Therapeutics, Inc. Director $87.9K Jun 24, 2024
CMMB Chemomab Therapeutics Ltd. Director Mar 16, 2023

Insider Transactions Reported by Claude Nicaise:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.